New therapeutic target in primary headaches – blocking the CGRP receptor

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.7, Iss.3, 2003-06, pp. : 377-383

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

5-HT1A Receptor, an Old Target for New Therapeutic Agents

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 12, 2008-01 ,pp. : 1024-1034

Bentham Science Publishers

Access to resources Recommend Favorite

Central Sensitisation Phenomena in Primary Headaches: Overview of a Preventive Therapeutic Approach

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 6, 2008-12 ,pp. : 524-535

Bentham Science Publishers

Access to resources Recommend Favorite

Blocking the interaction of vascular endothelial growth factor receptors with their ligands and their effector signaling as a novel therapeutic target for cancer: time for a new look?

By Bruce David Tan Peng H

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 10, 2011-10 ,pp. : 1413-1434

Informa Healthcare

Access to resources Recommend Favorite

The vitamin D receptor as a therapeutic target

By Campbell Moray J Adorini Luciano

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 5, 2006-10 ,pp. : 735-748

Informa Healthcare

Access to resources Recommend Favorite

The CCR2 receptor as a therapeutic target

By Feria Manuel Díaz-González Federico

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 1, 2006-01 ,pp. : 49-57

Informa Healthcare

Access to resources Recommend Favorite